Pfizer (PFE) Company Update Takes 5% of Share Value, RBC is Hosting a Management Call to Clarify Issue
Tweet Send to a Friend
RBC Capital analyst Randall Stanicky reiterated an Outperform rating and reinstated a $43.00 price target on Pfizer (NYSE: PFE) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
